575608-U

Discovery® DSC-Si 96-well solid phase extractio (SPE) Plate

bed wt. 50 mg/well, pk of 1

Manufacturer: Supelco

Synonym(S): Silica SPE 96-well plate

Select a Size

Pack Size SKU Availability Price
1 EA 575608-U-1-EA In Stock ₹ 46,276.88

575608-U - 1 EA

₹ 46,276.88

In Stock

Quantity

1

Base Price: ₹ 46,276.88

GST (18%): ₹ 8,329.838

Total Price: ₹ 54,606.718

product name

Discovery® DSC-Si SPE 96-well Plate, bed wt. 50 mg/well, pk of 1

material

PE frit (20 μm)polypropylene hardware

Quality Level

100

composition

bed wt., 50 mg/well

packaging

pk of 1

technique(s)

solid phase extraction (SPE): suitable

surface area

480 m2/g

matrix

silica gel base material (irregularly shaped, acid washed)

matrix active group

silica bonding

particle size

50 μm

Related Products

Img

Supelco

575603-U

bed wt. 100 mg/well, pk of 1...

Img

Supelco

575601-U

bed wt. 25 mg/well, pk of 1...

Img

Supelco

575615-U

bed wt. 100 mg/well, pk of 1...

Img

Supelco

57231

bed wt. 500 mg, volume 3 mL, pk of ...

Img

Supelco

57233

bed wt. 1 g, volume 6 mL, pk of 30...

Img

Supelco

57137

bed wt. 5 g, volume 20 mL, pk of 20...

Img

Supelco

57133

bed wt. 5 g, volume 20 mL, pk of 20...

Img

Supelco

57116

bed wt. 2 g, volume 12 mL, pk of 20...

Description

  • General description: Retention Mechanism: Normal phaseSample Matrix Compatibility: Organic solvents, oils, and lipidsUnbonded acid washed silica sorbent ideal for normal phase SPE and other modified flash techniquesOften used to separate or remove structurally similar molecules through successive elutions with increasingly polar solutionsThe most polar normal phase sorbent availableExcellent capacity for purifying solution phase combinatorial chemistry reactions when removing target molecules from reaction by-products and excess reagentsAvailable in Büchner Funnel configurations for easy scalability
  • Application: High-Throughput Mass Spectrometry for Biopharma: Utilizes the Discovery DSC-Si SPE 96-well plate for rapid and accurate biomolecule characterization, demonstrating its critical role in high-throughput analytical setups, enhancing productivity in biopharmaceutical analysis (Campuzano et al., 2022). Towards a Point-of-Care Diagnostic Platform for Multiplex Sensing: Highlights the application of Discovery DSC-Si SPE 96-well plates in developing advanced diagnostic platforms, specifically for detecting mild traumatic brain injury biomarkers, showcasing the plate′s versatility and reliability in clinical settings (Jović et al., 2022). Determination of Crizotinib in Plasma by LC-ESI-MS/MS: Demonstrates the use of Discovery DSC-Si SPE 96-well plates in pharmacokinetic studies, providing robust and efficient sample preparation methods for therapeutic drug monitoring and clinical research (Roberts et al., 2014). High-throughput Mass Spectrometric Cytochrome P450 Inhibition Screening: Applies the Discovery DSC-Si SPE 96-well plate in drug metabolism studies, specifically in the screening of cytochrome P450 enzyme inhibitors, which is crucial for predicting drug-drug interactions in drug development (Lim et al., 2013). Development of a High-Throughput SPE/MS Method for Cytochrome P450 Inhibition: Uses the Discovery DSC-Si SPE 96-well plate to enhance throughput in the pharmacological screening of drug candidates, underscoring its importance in the early stages of drug discovery to assess potential toxicities (Lim et al., 2010).
  • Legal Information: Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFETY INFORMATION

WGK

nwg

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable